Open Rome - Organize and Promote Epidemiological Network - Réseau d'Observation des Maladies et des Epidémies

Publications - 2024

Communications scientifiques

Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024"
Kassianos G , Civljak R, van Essen GA, Pecurariu OF, Froes F, Galev A, Kõivumägi K, Kristufkova Z, Kuchar E, Kyncl J, Maltezou HC1, Marković M, Mosnier A, Ortiz de Lejarazu y Leonardo R, Rossi A, Schelling J
Germs
21-10-2024
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population
Alvarez FP, Allard L, Bianic F, Bricout H, Crépey P, Gaillat J, Gavazzi G, Mosnier A, Launay O, Levant MC, Proshenska D, de Courville C
Journal of Medical Economics2024, Preproduction, 1-29
11-09-2024
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021–2022 influenza season
Bricout H, Levant MC, Assi N, Crépey P, Descamps D, Mari K, Gaillat J, Gavazzi G, Grenier B, Launay O, Mosnier A, Raguideau F, Watier L, Harris RC, Chit A
Clinical Microbiology and Infection (CMI)
27-08-2024
Infections à VRS : Covigie interroge médecins et pharmaciens sur la campagne d’immunisation des nourrissons
Mosnier A, Daviaud I et Cohen JM (Open Rome), Clairaz B et Barthelmé T (SFSPO), Rozaire O (URPS pharmaciens Auvergne Rhône-Alpes), Duhot D, Collignon-Portes R et Boisnault B (SFMG)
Concours Pluripro
11-07-2024
The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel.
Kassianos G, Cohen JM, Civljak R, Davidovitch N, Pecurariu OF, Froes F, Galev A, Ivaskeviciene I, Kõivumägi K, Kristufkova Z, Kuchar E, Kyncl J, Maltezou HC, Marković M, Nitsch-Osuch A, Ortiz de Lejarazu R, Rossi A, Schelling J, van Essen GA, Zavadska D.
Expert Rev Respir Med
23-04-2024

Communications affichées

Relative effectiveness (rVE) of the high-dose vs. standard-dose influenza vaccines in the French National health data system (SNDS) for people aged 65+ living in community, obtained using two approaches based on the propensity score
Grenier B, Assi N, Crépey P, Gaillat J, Gavazzi G, Levant MC, Launay O, Mosnier A, Watier L, Raguideau F, Bricout H
40th Annual Meeting of the International Society for Pharmacoepidemiology (ICPE), Berlin, 24-28 août 2024
27-08-2024
Prévention des infections à Virus Respiratoire Syncytial : la première campagne d’immunisation des nourrissons vue de la ville
Mosnier A, Daviaud I, Clairaz B, Rozaire O, Duhot D, Collignon-Portes R, Barthelme T, Cohen JM, Boisnault P
25èmes Journées Nationales d'Infectiologie (JNI), Deauville, 12-14 juin 2024
12-06-2024
Une étude de cohorte rétrospective évaluant l’efficacité en vie réelle du vaccin grippal haute dose comparé au dose standard en France en 2021/2022 : robustesse des résultats via 2 méthodes d’ajustement
Bricout H, Levant M, Launay O, Mosnier A, Watier L, Grenier B, Raguideau F, Gaillat J, Crepey P, Gavazzi G, Chit A.
25èmes Journées Nationales d'Infectiologie (JNI), Deauville, 12-14 juin 2024
12-06-2024